Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoka Tabata

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
European Heart Journal Open|November 1, 2023
Tenascin-C as a potential marker for immunohistopathology of doxorubicin-induced cardiomyopathyTatsuya Nishikawa, Mikio Shiba, Yoshihiko Ikeda, et al.
Stem Cell Reports|January 22, 2022
Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytesHiroyuki Inoue, Satoki Nakamura, Shuichiro Higo, et al.
Circulation. Genomic and Precision Medicine|July 21, 2022
Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for <i>TNNT2</i> Δ160E-Induced CardiomyopathyTakumi Kondo, Shuichiro Higo, Mikio Shiba, et al.
Journal of Cardiovascular Translational Research|June 25, 2026
Tracing the pathogenic PLN p.(Arg14del) variant across the globe; more than just a local curiosityEsmée van Drie, Freyja H M van Lint, Rob Zwart, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
European Heart Journal Open|November 1, 2023
Tenascin-C as a potential marker for immunohistopathology of doxorubicin-induced cardiomyopathyTatsuya Nishikawa, Mikio Shiba, Yoshihiko Ikeda, et al.
Stem Cell Reports|January 22, 2022
Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytesHiroyuki Inoue, Satoki Nakamura, Shuichiro Higo, et al.
Circulation. Genomic and Precision Medicine|July 21, 2022
Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for <i>TNNT2</i> Δ160E-Induced CardiomyopathyTakumi Kondo, Shuichiro Higo, Mikio Shiba, et al.
Journal of Cardiovascular Translational Research|June 25, 2026
Tracing the pathogenic PLN p.(Arg14del) variant across the globe; more than just a local curiosityEsmée van Drie, Freyja H M van Lint, Rob Zwart, et al.
Pageof 2